Waters Launches New Platform for GLP-1 and LNP Analytics
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MILFORD, Massachusetts, USA – June 8, 2026 Waters Corporation has introduced its BioResolve™ Peptide and GTxResolve™ Lipid Phenyl-Hexyl+ and...
WARSAW, Poland, June 3, 2026 Ingenix, an emerging artificial intelligence company focused on transforming drug discovery through advanced biological...
Stockholm, Sweden | April 30, 2026 Moleculent has announced the successful closing of a $20 million financing round, aimed...
Brussels, Belgium & Atlanta, Georgia – March 24, 2026 Strategic Biologics Expansion to Strengthen Global Supply In a major...
Redwood City, CA – March 17, 2026 – R1 Therapeutics has officially emerged from stealth mode, announcing an oversubscribed...
NEWTOWN, Pa., Nov. 25, 2025 — Catalyx, a global leader in machine vision, automation, and digital transformation for highly...
CINCINNATI, OHIO, September 16, 2025 – Meridian Bioscience, Inc., a global leader in diagnostics and life science raw materials,...
